SUSQUEHANNA INTERNATIONAL GROUP, LLP - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 90 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$692,501
+19.4%
721,355
-6.7%
0.00%
Q1 2023$580,153
+149.4%
773,537
+22.7%
0.00%
Q4 2022$232,652
-44.6%
630,385
-35.4%
0.00%
Q3 2022$420,000
-1.4%
976,119
+78.6%
0.00%
Q2 2022$426,000
-20.1%
546,493
+32.4%
0.00%
Q1 2022$533,000
-77.0%
412,865
-77.4%
0.00%
Q4 2021$2,318,000
+4.0%
1,824,564
+78.5%
0.00%
Q3 2021$2,228,000
-19.7%
1,022,190
+38.1%
0.00%
Q2 2021$2,775,000
+80.2%
739,934
+56.6%
0.00%
Q1 2021$1,540,000
-45.6%
472,593
-43.0%
0.00%
Q4 2020$2,830,000
+65.2%
829,694
+97.7%
0.00%
Q3 2020$1,713,000
+358.0%
419,746
+278.7%
0.00%
Q2 2020$374,000
+6.6%
110,840
-26.3%
0.00%
Q1 2020$351,000
-80.8%
150,447
-70.0%
0.00%
Q4 2019$1,828,000
-69.0%
502,326
-29.3%
0.00%
-100.0%
Q3 2019$5,895,000
-49.0%
710,690
-47.1%
0.00%0.0%
Q2 2019$11,556,000
+752.2%
1,342,298
+958.6%
0.00%
Q1 2019$1,356,000
-9.0%
126,800
-25.6%
0.00%
Q4 2018$1,490,000
-75.9%
170,348
-53.7%
0.00%
-100.0%
Q3 2018$6,175,000
-33.6%
367,554
-17.2%
0.00%
-50.0%
Q2 2018$9,306,000
+92.0%
443,955
+47.4%
0.00%
+100.0%
Q1 2018$4,846,000
+44.0%
301,200
+69.6%
0.00%
+100.0%
Q4 2017$3,365,000
-4.5%
177,594
-29.1%
0.00%0.0%
Q3 2017$3,522,000
+754.9%
250,321
+352.7%
0.00%
Q2 2017$412,000
-19.4%
55,300
-29.6%
0.00%
Q1 2017$511,000
-14.4%
78,600
-41.7%
0.00%
Q4 2016$597,000
+206.2%
134,721
+223.1%
0.00%
Q3 2016$195,000
-36.3%
41,700
-10.5%
0.00%
Q2 2016$306,000
+32.5%
46,600
+28.3%
0.00%
Q1 2016$231,000
+79.1%
36,313
+69.9%
0.00%
Q4 2015$129,000
-83.8%
21,378
-83.9%
0.00%
Q3 2015$796,000
+8.9%
132,954
+24.4%
0.00%
Q2 2015$731,000
-60.8%
106,910
-65.2%
0.00%
Q1 2015$1,863,000
+5.2%
306,943
+20.1%
0.00%
Q4 2014$1,771,000
-35.5%
255,608
-24.3%
0.00%
-100.0%
Q3 2014$2,747,000
-23.3%
337,491
-23.4%
0.00%
-50.0%
Q2 2014$3,581,000
-1.0%
440,456
-4.5%
0.00%0.0%
Q1 2014$3,617,000
-18.4%
461,352
-7.9%
0.00%
+100.0%
Q4 2013$4,433,000
-1.4%
500,873
-6.5%
0.00%
-50.0%
Q3 2013$4,495,000
+5.0%
535,764
-6.7%
0.00%0.0%
Q2 2013$4,282,000573,9760.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,020,583$15,053,0001.77%
Piermont Capital Management Inc. 247,882$1,847,0000.53%
BARD ASSOCIATES INC 129,380$964,0000.44%
Sonora Investment Management, LLC 239,202$1,782,055,0000.34%
TFS CAPITAL LLC 97,526$727,0000.28%
Alambic Investment Management, L.P. 165,001$1,229,0000.15%
KENNEDY CAPITAL MANAGEMENT LLC 491,075$3,659,0000.07%
Renaissance Technologies 6,071,817$45,235,0000.06%
Granite Investment Partners, LLC 97,023$723,0000.05%
ClariVest Asset Management LLC 241,909$1,802,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders